|
Re: Only 15 trading days left...
|
1
|
Resverlogix Corp.
|
Aug 03, 2017 02:41PM
|
|
Re: Debt and 28 August
|
2
|
Resverlogix Corp.
|
Aug 02, 2017 05:34PM
|
|
Re: Share price - some thoughts
|
1
|
Resverlogix Corp.
|
Aug 01, 2017 03:07PM
|
|
Share price - some thoughts
|
2
|
Resverlogix Corp.
|
Aug 01, 2017 11:00AM
|
|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
5
|
Resverlogix Corp.
|
Jul 26, 2017 06:28PM
|
|
Re: Congrats
|
1
|
Resverlogix Corp.
|
Jul 25, 2017 12:42PM
|
|
Congrats
|
6
|
Resverlogix Corp.
|
Jul 25, 2017 11:39AM
|
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 22, 2017 04:44PM
|
|
Re: Gilead GS-5829 Perspective
|
3
|
Zenith Epigenetics
|
Jul 21, 2017 02:54PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Jul 19, 2017 04:00PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Jul 18, 2017 03:19PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Jul 15, 2017 12:58PM
|
|
Re: Update
|
2
|
Zenith Epigenetics
|
Jul 15, 2017 12:40PM
|
|
Re: Lobbying Firm and Resverlogix
|
2
|
Resverlogix Corp.
|
Jul 15, 2017 12:31PM
|
|
Re: DM
|
2
|
Resverlogix Corp.
|
Jul 14, 2017 04:21PM
|
|
Re: Pascal Soriot
|
5
|
Resverlogix Corp.
|
Jul 13, 2017 10:37AM
|
|
Re: Update
|
4
|
Resverlogix Corp.
|
Jul 12, 2017 02:59PM
|
|
Update
|
2
|
Resverlogix Corp.
|
Jul 12, 2017 10:55AM
|
|
Re: 002399:CH
|
1
|
Resverlogix Corp.
|
Jul 11, 2017 09:29PM
|
|
Re: 002399:CH
|
|
Resverlogix Corp.
|
Jul 11, 2017 09:23PM
|
